Prescribing of evidence-based diabetes pharmacotherapy in patients with metabolic dysfunction-associated steatohepatitis

INTRODUCTION: Metabolic dysfunction-associated steatohepatitis (MASH) is highly prevalent in type 2 diabetes (T2D). Pioglitazone and glucagon-like peptide-1 receptor agonists (GLP-1RA) are medications used in T2D that can resolve MASH and should be considered in all patients with T2D and MASH. We as...

Descripción completa

Detalles Bibliográficos
Autores principales: Alexopoulos, Anastasia-Stefania, Parish, Alice, Olsen, Maren, Batch, Bryan C, Moylan, Cynthia, Crowley, Matthew J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Epidemiology/Health services research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689360/
https://www.ncbi.nlm.nih.gov/pubmed/38030391
http://dx.doi.org/10.1136/bmjdrc-2023-003763

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689360/
https://www.ncbi.nlm.nih.gov/pubmed/38030391
http://dx.doi.org/10.1136/bmjdrc-2023-003763

Ejemplares similares